Law360 (January 28, 2020, 2:22 PM EST) -- On Jan. 15, the United States and China announced an economic and trade deal, the "phase one" trade agreement, which could significantly improve the ability of U.S. and non-U.S. drug companies to protect their intellectual property rights and market their innovative pharmaceutical products in China.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile